Efficacy Analysis the Budesonide Formoterol Powder Inhalation Combined with Baduanjin in the Treatment of Pneumoconiosis
Objective To explore the clinical efficacy of Budipine formoterol powder inhalation combined with Baduanjin in the treatment of pneumoconiosis.Methods Seventy-seven patients diagnosed with pneumoconiosis who visited our hospital and General Hospital of Jingmei Group from January 2022 to March 2024 were selected as subjects and divided into a control group(38 cases)and an observation group(39 cases).The control group was treated with Budipine formoterol powder inhalation,while the observation group received Baduanjin interven-tion on the basis of the control group.Both groups were evaluated for clinical efficacy and adverse reactions using pulmonary function indica-tors,includes forced vital capacity(FVC),forced expiratory volume in one second(FEV1),and the ratio of FEV1 to FVC(FEV1/FVC)and 6-minute walking distance before treatment,after 3 months of treatment,and after 6 months of treatment.Results Compared with be-fore treatment,pulmonary function,6-min walking distance and other indexes of the two groups were improved,and the difference was statis-tically significant(P＜0.05).The improvement of lung function and 6 min walking distance in the observation group was better than that in the control group,and the difference was statistically significant(P＜0.05).Adverse reactions occurred in1 patient in the control group and 2 patients in the observation group.Conclusion Budipine formoterol powder inhalation combined with Baduanjin in the treatment of pneu-moconiosis can significantly improve the lung function and enhance exercise endurance,with good safety.
lung-bi diseasepneumoconiosisBudesonide formoterol powder inhalationBaduanjintherapy of integrated traditional Chinese and Western medicine
NETL
NSTL
万方数据
